Health outcomes following liver function testing in primary care: A retrospective cohort study

Family Practice

Volumn 26, Issue 4, 2009, Pages 251-259

  McLernon, David J ^a   Donnan, Peter T ^b   Ryder, Stephen ^c   Roderick, Paul ^d   Sullivan, Frank M ^b   Rosenberg, William ^e   Dillon, John F ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Liver disease; Liver function tests; Mortality; Sensitivity; Survival

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE;

ABNORMAL LABORATORY RESULT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; LIVER DISEASE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; OUTCOME ASSESSMENT; PRIMARY HEALTH CARE; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; UNITED KINGDOM;

CAUSE OF DEATH; COHORT STUDIES; FEMALE; HEALTH STATUS; HUMANS; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MEDICAL RECORD LINKAGE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; SCOTLAND; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 67949122062     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmp025     Document Type: Article

References (24)

1. Van Walraven C, Naylor CD. Do we know what inappropriate laboratory utilization is? A systemic review of laboratory clinical audits. J Am Med Assoc 1998; 280: 550-8.
2. Mann RE, Smart RG, Govoni R. The epidemiology of alcoholic liver disease. Alcohol Res Health 2003; 27: 209-19.
3. Watson JP, Brind AM, Chapman CE et al. Hepatitis C virus: epidemiology and genotypes in the north east of England. Gut 1996; 38: 269-76.
4. Bellentani S, Tiribelli C, Saccoccio G et al. Prevalence of chronic liver disease in the general population of northern Italy: The Dionysos study. Hepatology 1994; 20: 1442-9.
5. Fatatsuka M, Kitano T, Nagano M et al. An epidemiological study with risk analysis of liver disease in the general population living in a methyl mercury polluted area. J Epidemiol Community Health 1992; 46: 237-40.
6. Sorensen HT, Moller-Petersen JF, Felding P, Andreasen C, Nielsen JO. Epidemiology of abnormal liver function tests in general practice in a defined population in Denmark. Dan Med Bull 1991; 38: 420-2.
7. Kim HC, Nam CM, Jee SH et al. Normal serum aminotransferase concentration and risk of mortality from liver diseases: Prospective cohort study. Br Med J 2004; 328: 983-6.
8. Roderick P. CommDntary: Liver function tests: defining what's normal. Br Med J 2004; 328: 987.
9. Sherwood P, Lyburn I, Brown S, Ryder S. How are abnormal results for liver function tests dealt with in primary care? Audit of yield and impact. Br Med J 2001; 322: 276-8.
10. Donnan PT, McLernon D, Steinke D et al. Development of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE). BMC Health Serv Res 2007; 7: 54.
11. The Health Informatics Centre. Welcome to the Health Informatics Centre (HIC). http://www.dundee.ac.uk/hic. 2007 (accessed on 24 April 2009).
12. Carstairs V, Morris R. Deprivation and mortality: An alternative to social class? Community Med 1989; 11: 210-9.
13. Morris AD, Boyle DI, MacAlpine R et al. The diabetes audit and research in Tayside Scotland (darts) study: Electronic record linkage to create a diabetes register. Br Med J 1997; 315: 524-8.
14. Steinke DT, Weston TL, Morris AD, MacDonald TM, Dillon JF. The epidemiology of liver disease in Tayside database: A population-based record-linkage study. J Biomed Inform 2003; 35: 186-93.
15. Steinke DT, Weston TL, Morris AD, MacDonald TM, Dillon JF. Epidemiology and economic burden of viral hepatitis: An observational population based study. Gut 2002; 50: 100-5.
16. Evans JMM, MacDonald TM. Record-linkage for pharmacovigilance in Scotland. Br J Clin Pharm 1999; 47: 105-10.
17. Begg CB, Greenes RA. Assessment of diagnostic tests when disease verification is subject to selection bias. Biometrics 1983; 39 207-15.
18. McLernon DJ, Donnan PT, Sullivan F, Gray M, Weller D. Receiver operating characteristics of the prostate specific antigen test in an unselected population. J Med Screen 2006; 13: 102-7.
19. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: Wiley, 1987.
20. Scottish Enhanced Functionality. Scottish Enhanced Functionality (SEF). http://www.sef.scot.nhs.uk/ (accessed on 24 April 2009).
21. Prati D, Taioli E, Zanella A et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002; 137: 1-9.
22. Schalk BWM, Visser M, Bremmer MA et al. Change of serum albumin and risk of cardiovascular disease and all-cause mortality: Longitudinal Aging Study Amsterdam. Am J Epidemiol 2006; 164: 969-77.
23. Soriano S, Gonzalez L, Martin-Malo A et al. C-reactive protein and low albumin are predictors of morbidity and cardiovascular events in chronic kidney disease (CKD) 3-5 patients. Clin Nephrol 2007; 67: 352-7.
24. Omran ML, Morley JE. Assessment of protein energy malnutrition in older persons, part II: Laboratory evaluation. Nutrition 2000; 16: 131-40.